20:08 EDT Cathie Wood’s ARK Investment buys 173K shares of Guardant Health (GH) today
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GH:
- Guardant granted Breakthrough Device designation for multi-cancer detection test
- Guardant Health’s Strategic Advancements and Innovative Growth Drive Buy Rating
- Guardant Health’s Shield Test Gains Momentum with NCCN Guideline Inclusion, Driving Growth Prospects
- Cathie Wood’s ARK Investment buys 158.7K shares of Guardant Health today
- Guardant Health announces NCCN has included Shield blood test in CRC guidelines